High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome
Modern Pathology2014Vol. 28(4), pp. 552–563
Citations Over TimeTop 10% of 2014 papers
Arjen H.G. Cleven, Valentina Nardi, Chi Young Ok, Maitrayee Goswami, Paola Dal Cin, Zongli Zheng, A. John Iafrate, Myrurgia Abdul Hamid, Sa A. Wang, Robert P. Hasserjian
Related Papers
- → Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation(2015)52 cited
- → Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults(2012)16 cited
- → Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts(2012)14 cited
- → 14 A PHASE 2, DOSE-FINDING STUDY OF SOTATERCEPT (ACE-011) IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (MDS) OR NON-PROLIFERATIVE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) AND ANEMIA REQUIRING TRANSFUSION(2015)11 cited
- → PB2082 PHENOTYPIC ALTERATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA: SIMILARITIES AND DIFFERENCES MYELODYSPLASTIC SYNDROMES(2019)